Department of Laboratory Medicine, The Affiliated Hospital of Zunyi Medical University, Zunyi, 563003, People's Republic of China.
School of Laboratory Medicine, Zunyi Medical University, Zunyi, 563003, People's Republic of China.
Sci Rep. 2021 Jun 29;11(1):13483. doi: 10.1038/s41598-021-92466-8.
Valproic acid (VPA) is widely used as a eutherapeutic and safe anticonvulsant drug, but the mechanism is not well elucidated. Histone deacetylases (HDACs) were first identified as direct targets of VPA. Many loss-of function mutants in S. pombe have been shown to be VPA sensitive but not sensitive to other HDAC inhibitors, such as sodium butyrate or trichostatin A (TSA). This difference suggests that there are multiple VPA target genes. In the current study, we isolated a VPA-sensitive (vas) mutant, vas4-1, and cloned the VPA target gene vas4/vrg4 by performing complementation experiments. The vas4/vrg4 gene encodes a putative Golgi GDP-mannose transporter, Vrg4, which is highly homologous with ScVrg4p. Physiological experiments indicated that SpVrg4p is involved in maintaining cell wall integrity (CWI) under high- or low-temperature stress. The results of a coimmunoprecipitation assay suggested that SpVrg4p may be transferred from the ER to the Golgi through SpGot1p loaded COPII vesicles, and both single and double mutations (S263C and A271V) in SpVrg4p compromised this transfer. Our results suggested that CWI in S. pombe is compromised under temperature stress by the VPA-sensitive vas4 mutant.
丙戊酸(VPA)被广泛用作治疗和安全的抗惊厥药物,但作用机制尚未阐明。组蛋白去乙酰化酶(HDACs)最初被确定为 VPA 的直接靶标。许多 S. pombe 的功能丧失突变体已被证明对 VPA 敏感,但对其他 HDAC 抑制剂(如丁酸钠或曲古抑菌素 A(TSA))不敏感。这种差异表明存在多个 VPA 靶基因。在本研究中,我们分离了一个 VPA 敏感(vas)突变体 vas4-1,并通过互补实验克隆了 VPA 靶基因 vas4/vrg4。vas4/vrg4 基因编码一种假定的高尔基体 GDP-甘露糖转运蛋白,Vrg4,与 ScVrg4p 高度同源。生理实验表明,SpVrg4p 参与维持细胞壁完整性(CWI)在高温或低温应激下。共免疫沉淀实验的结果表明,SpVrg4p 可能通过 SpGot1p 装载的 COPII 囊泡从内质网转移到高尔基体,SpVrg4p 的单个和双突变(S263C 和 A271V)削弱了这种转移。我们的结果表明,在温度应激下,S. pombe 的 CWI 会被 VPA 敏感的 vas4 突变体破坏。